At approximately 1.5 mg of semaglutide, this dose matches the standard therapeutic level for type 2 diabetes management and begins approaching the weight management dose range
At 48 weeks in the Phase 2 trial, weight-loss curves were still declining participants had not reached a plateau
In early trials, average weight loss reached 25% by week 4 and up to 24.2% by 48 weeks (12mg dose)
Specifically, increased temperature may promote reactive oxygen species (ROS) production and mitochondrial dysfunction, disrupt Sertoli cellgerm cell interactions, and induce apoptosis of spermatogenic cells
It's like having a whole beauty squad working from the inside out
If youre considering either medication, talk to a doctor who understands weight management, not just prescription pads